Abstract:The main protease (Mpro) of SARS-CoV-2 is an essential enzyme for viral replication, making it a critical target for antiviral drug development. While current Mpro inhibitors, such as Paxlovid, focus on active site binding, resistance mutations are emerging, underscoring the need for alternative strategies. Dimerization of Mpro, necessary for its enzymatic activity, presents a promising but underexplored target for drug development. However, knowledge gaps remain in understanding the dynamic conformational changes and network of residues that stabilize the dimer interface. In this study, we captured the transient dynamics of Mpro dimerization and the conformational changes at the dimer interface induced by inhibitor binding. Integrat-ing stable isotope labeling and native mass spectrometry with hydrogen-deuterium exchange, we provided time-resolved insights into the structural dynamics of Mpro in its intact dimeric form. We employed N15 isotopic labeling of Mpro to investi-gate subunit exchange and dissociation kinetics during dimerization, both in the presence and absence of peptidomimetic inhibitors, including Nirmatrelvir, GC376, and MPI8. Our findings revealed that peptidomimetic inhibitor binding inhibited dimer dissociation, altering the dynamics of subunit exchange. Moreover, we identified significant conformational changes across Mpro's three domains and at the dimer interface upon inhibitor binding. Notably, hydrogen-deuterium exchange pro-files transitioned from bimodal to unimodal distributions in the N-finger region when Mpro was complexed with Nirmatrelvir, suggesting distinct structural alterations that stabilize the dimeric form. By filling critical knowledge gaps in the understand-ing of Mpro dimerization and its inhibitor-induced dynamics, our study provides a foundation for the rational design of next-generation Mpro inhibitors targeting the dimer interface.

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

C-Terminal Domain of Sars-Cov Main Protease Can Form A 3d Domain-Swapped Dimer

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS

Mechanism of 3d Domain Swapping for M-Pro-C: Clues from Molecular Simulations

Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.

Crystal structures of main protease (M pro ) mutants of SARS-CoV-2 variants bound to PF-07304814

Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation

A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link Between Three Residues C22, C44, and K61 is Frequently Observed in the SARS-CoV-2 Main Protease.

Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814

Ph-Dependent Conformational Flexibility of the SARS-CoV Main Proteinase (mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses

Foldon Unfolding Mediates the Interconversion Between Mpro-C Monomer and 3D Domain-Swapped Dimer

Inhibition of Subunit Exchange and N-Finger Rearrangement in SARS-CoV-2 Main Protease by Peptidomimetic Inhibitors

Crystal Structure of SARS-CoV-2 Main Protease (mpro) Mutants in Complex with the Non-Covalent Inhibitor CCF0058981.

The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops is Determined by Ligand Binding and Interprotomer Allostery

Characterization of alternate encounter assemblies of SARS-CoV-2 main protease

Dimeric and monomeric conformation of SARS-CoV-2 main protease: New technical approaches based on IR radiation

Without Its N-Finger, the Main Protease of Severe Acute Respiratory Syndrome Coronavirus Can Form a Novel Dimer Through Its C-Terminal Domain

A Novel Y-Shaped, S-O-N-O-S-Bridged Crosslink between Three Residues C22, C44, and K61 Is a Redox Switch of the SARS-CoV-2 Main Protease

Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2